Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa.

Although all systemic inflammation-based biomarkers investigated are more or less associated with HS severity, the PIV appears to have the best performance in this regard. It may be employed in adjunction with the clinical scores for treatment decision making or clinical trial assessments.